Mirum Pharmaceuticals Inc (MIRM)
Mirum Pharma - Mirum Pharmaceuticals and Incyte Announce Pivotal Late-Breaking Results for Zilurgisertib in Fibrodysplasia Ossificans Progressiva Accepted for Presentation at ENDO 2026
Mirum Pharma - Mirum Pharmaceuticals and Incyte Announce Pivotal Late-Breaking Results for Zilurgisertib in Fibrodysplasia Ossificans Progressiva Accepted for Presentation at ENDO 2026
Nucleus Research Names Zebra Workcloud Task and Workforce Management Solutions Enterprise Leaders
Xos announces $6 million common stock registered direct offering
Mirum Pharmaceuticals and Incyte Announce Pivotal Late-Breaking Results for Zilurgisertib in Fibrodysplasia Ossificans Progressiva Accepted for Presentation at ENDO 2026
Net Asset Value(s)
SenesTech Expands Distribution ofEvolve® Rodent Birth Control™ into Bermuda
Quanterix Appoints Industry Veteran Geoff Albrecht as Senior Vice President and General Manager of Diagnostics
Emergent BioSolutions Supports Victoria’s Voice Foundation’s National Naloxone Awareness Day to Help Save Lives from Opioid Overdose
Amneal Pharmaceuticals, Inc. - Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution
Net Asset Value(s)